CarilliA, FavisG, SundharkrishnanL, et al.Severe dermatologic reactions with bendamustine: A case series. Case Rep Oncol. 2014; 7(2):465–470.
2.
DumontM, Ram-WolffC, RoelensM, et al.Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas. Br J Dermatol. 2019; 181(6):1315–1317.
3.
TetartF, WalshS, MilpiedB, et al.Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management. J Eur Acad Dermatol Venereol. 2024; 38(11):2073–2081.
4.
HarberID, AdamsKV, CasamiquelaK, et al.Bendamustine-Induced Acute Generalized Exanthematous Pustulosis Confirmed by Patch Testing. Dermatitis. 2017; 28(4):292–293.